NCT00379067View on ClinicalTrials.gov

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

PHASE4CompletedINTERVENTIONAL
Enrollment

882

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin OCAS

Adrenoceptor antagonist

DRUG

Placebo

placebo

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Astellas Pharma Europe Ltd.

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY